CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 40,257	$ 55,699
Accounts receivable	509	1,070
Marketable securities	46,694	46,361
Research and development incentive receivable	665	640
Inventory	3,089	2,817
Prepaid expenses and other current assets	4,483	5,588
Total current assets	95,697	112,175
Property and equipment, net	487	776
Goodwill	17,351	17,351
Finite-Lived Intangible Assets, Net	9,813	10,000
Right-of-use assets	3,652	4,065
Other assets	3,013	2,080
Total assets	130,013	146,447
Current liabilities:
Accounts payable	11,115	8,621
Accrued expenses (Note 9)	12,611	23,005
Deferred revenue	855	0
Current portion of lease liability	1,303	1,251
Total current liabilities	25,884	32,877
Long-term debt, including accretion, net of discount (Note 10)	75,629	75,425
Lease liabilities	1,109	1,410
Warrant liability (Note 5)	2,925	13,755
Deferred revenue	955	0
Other liabilities	567	831
Total liabilities	107,069	124,298
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value. 10,000,000 shares authorized and no shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	0	0
Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; 5,788,745 and 5,698,231 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	6	6
Additional paid-in capital	538,139	537,620
Accumulated other comprehensive loss	(128)	(122)
Accumulated deficit	(515,073)	(515,355)
Total stockholders’ equity	22,944	22,149
Total liabilities and stockholders’ equity	$ 130,013	$ 146,447